vivoVerse Inc.

vivoVerse, Inc., formerly operating as Newormics LLC, develops and manufactures advanced microfluidics, automation, and AI/ML technologies to rapidly and ethically test toxicology/safety profiles of chemicals using C. elegans as a New Approach Methodology (NAM). With a new class of instruments, software, and services, we aim at reducing animal testing while providing rapid and cost-effective services to our industry customers for bringing their new products to the market.